Shawn Young, MD
Surgical Oncology · Denver, CONPI 1437209822
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (58.4%), education and food and beverage — rather than concentrated in one kind of arrangement. 15 manufacturers reported payments, led by Boehringer Ingelheim at 51.7% of the total. Reporting peaked in 2020 at $3,761 and has fallen 98.2% since, to $69 in 2025.
Across 31 payments — averaging $325.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boehringer Ingelheim$5K
- Intuitive Surgical$3K
- Covidien LP$675
- AbbVie$346
- Aroa Biosurgery Incorporated$133
- Merit Medical Systems Inc$96
- plus $405 from 9 others
What the payments were for
- Consulting fees$5,89558%
- Food & beverage$1,19812%
- Education$3,00030%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boehringer Ingelheim | 2 | $5,220 |
| Intuitive Surgical | 3 | $3,218 |
| Covidien LP | 1 | $675 |
| AbbVie | 6 | $346 |
| Aroa Biosurgery Incorporated | 5 | $133 |
| Merit Medical Systems Inc | 1 | $96 |
| Davol Inc. | 3 | $89 |
| Angiodynamics, Inc. | 1 | $86 |
| Hologic Sales And Service, LLC | 2 | $75 |
| Medtronic | 2 | $41 |
| Teleflex LLC | 1 | $38 |
| Stryker | 1 | $27 |
| Integra Lifesciences Corporation | 1 | $21 |
| Springworks Therapeutics, Inc. | 1 | $18 |
| Iovance Biotherapeutics, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$3,135
- GILOTRIF$2,900
- Creon$125
How this compares
$10,093 in reported general payments places this provider in the 75th percentile of 25 surgical oncology providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other surgical oncology in Denver
- Eric LiuDenver$529K
- Kayla GriffithDenver$29K
- Carlton BarnettDenver$9K
- Cameron Ward CokerDenver$2K
- Gerald HaaseDenver$338
- Camille StewartHighlands Ranch$27K
- Martin McCarterAurora$17K
- Blake BabcockParker$15K
- Travis MasonGreeley$8K
- Jodi WidnerHighlands Ranch$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.